MOLECULES SPECIFIC FOR NPFF RECEPTORS AND USES THEREOF

Details for Australian Patent Application No. 2002330090 (hide)

Owner SYNAPTIC PHARMACEUTICAL CORPORATION

Inventors WETZEL, John; BOTEJU, Lakmal, W.; KONKEL, Michael, J.; KAWAKAMI, Joel, K.

Pub. Number AU-A-2002330090

PCT Number PCT/US02/30258

PCT Pub. Number WO2003/026575

Priority 09/962,920 24.09.01 US

Filing date 24 September 2002

Wipo publication date 7 April 2003

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 09/962,920 24.09.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2002330090

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002330091-METHOD FOR RECOVERING AND ANALYZING A CELLULAR COMPONENT OF CULTURED CELLS WITHOUT HAVING TO HARVEST THE CELLS FIRST

2002330089-PROCESS FOR CONVERTING LIGHT